Sustainable KLH Technologies for Growing Markets
Quick Links

PRESS RELEASES

Stellar Biotechnologies Welcomes Malcolm Gefter, Ph.D. to Corporate and Scientific Advisory Boards Jul 12, 2010
Stellar Biotechnologies, Inc. is pleased to announce that eminent biochemist,...  Read More
Stellar Biotechnologies Appoints John S. Sundsmo, Ph.D. to VP, Research & IP Management and Daniel C. Adelman, M.D. as Member of SAB Jun 29, 2010
Stellar Biotechnologies, Inc. (OTC: SBOTF - TSX-V: KLH) has appointed John S....  Read More

THE KEY TO STELLAR

Stellar KLH is used in conjugate therapeutic vaccines and other biomedical products. Stellar maximizes the impact of its intellectual property and production platform supplying medical-grade KLH into the growing research and pharmaceutical markets.
Click here for our corporate profile

KLH PRODUCT DEVELOPMENT

Keyhole limpet hemocyanin (KLH) is a highly potent immunostimulatory protein. The molecule has an extensive history of safe and effective use in humans and comes solely from the rare keyhole limpet. Stellar has technology for the maintenance of the animal, the non-lethal extraction of the critical molecule and profitable refinement processes for various forms of KLH. Read more...

Download Presentation
Subscribe to RSS
Receive Updates